This article is from the source 'guardian' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.theguardian.com/science/2016/jan/23/protein-in-breast-milk-could-be-used-to-combat-certain-bacteria-scientists-find

The article has changed 4 times. There is an RSS feed of changes available.

Version 0 Version 1
Protein in breast milk could be used to combat certain bacteria, scientists find Breast milk protein could be used in fight against antibiotic resistance
(about 9 hours later)
Part of a protein found in breast milk could be used to wipe out certain types of bacteria, scientists have found. An antibiotic developed from human breast milk could combat certain drug-resistant bacteria, British scientists have found.
The study, by the National Physical Laboratory (NPL) and University College London, found that the minuscule fragment, less than a nanometre in width, is responsible for giving the protein its anti-microbial properties. Tackling antibiotic-resistant bacteria – known as superbugs – is a priority for the government. A panel set up by David Cameron forecast that superbugs would cost the world ten million lives and £700bn a year by 2050 if the problem went unchecked.
The breakthrough, developed by the National Physical Laboratory (NPL) and University College London, found that the minuscule fragment, less than a nanometre in width, is responsible for giving the protein its anti-microbial properties.
This is what makes breast milk so important in protecting infants from diseases in their first months of life. The protein, called lactoferrin, effectively kills bacteria, fungi and even viruses on contact.This is what makes breast milk so important in protecting infants from diseases in their first months of life. The protein, called lactoferrin, effectively kills bacteria, fungi and even viruses on contact.
After identifying the fragment, scientists re-engineered it into a virus-like capsule that can recognise and target specific bacteria and damage them on contact, but without affecting any surrounding human cells.After identifying the fragment, scientists re-engineered it into a virus-like capsule that can recognise and target specific bacteria and damage them on contact, but without affecting any surrounding human cells.
Related: Antibiotic resistance: the race to stop the 'silent tsunami' facing modern medicineRelated: Antibiotic resistance: the race to stop the 'silent tsunami' facing modern medicine
Hasan Alkassem, a student who worked on the project, said: “The capsules acted as projectiles … with bullet speed and efficiency.”Hasan Alkassem, a student who worked on the project, said: “The capsules acted as projectiles … with bullet speed and efficiency.”
The team suggested this could help the fight against antibiotic resistance by serving as “delivery vehicles” for cures. The capsules could even pave the way for treatments for previously incurable diseases such as sickle-cell disease, cystic fibrosis or Duchenne muscular dystrophy.The team suggested this could help the fight against antibiotic resistance by serving as “delivery vehicles” for cures. The capsules could even pave the way for treatments for previously incurable diseases such as sickle-cell disease, cystic fibrosis or Duchenne muscular dystrophy.
In an interview with The Times, Dame Sally Davies, chief medical officer for England, said more needs to be done by governments and experts to tackle the antibiotics issue. “We need on average 10 new antibiotics every decade. If others do not work with us, it’s not something we can sort on our own,” she said. “This is a global problem. I am optimistic about this. The science is crackable. It’s doable.” In an interview with the Times, Dame Sally Davies, the chief medical officer for England, said more needed to be done by governments and experts to tackle the antibiotics issue. “We need on average 10 new antibiotics every decade. If others do not work with us, it’s not something we can sort on our own,” she said. “This is a global problem. I am optimistic about this. The science is crackable. It’s doable.”
Colin Garner, honorary professor of pharmacology at the University of York and head of the charity Antibiotic Research UK, said the situation was too urgent to wait for international consensus. “The pipeline of new drugs had dried up and the problem was on the brink of becoming ‘intractable’, he told The Times. Colin Garner, honorary professor of pharmacology at the University of York and head of the charity Antibiotic Research UK, said the situation was too urgent to wait for international consensus. “The pipeline of new drugs had dried up and the problem was on the brink of becoming intractable, he told the Times.
“My heart sinks when I hear the term ‘global initiative’. How long has it taken the world to come to a sort of consensus about climate change?” he said.“My heart sinks when I hear the term ‘global initiative’. How long has it taken the world to come to a sort of consensus about climate change?” he said.
“The problem of antibiotic resistance will be at least as intractable because each nation takes a different view of what is required.”“The problem of antibiotic resistance will be at least as intractable because each nation takes a different view of what is required.”
The NPL findings are reported in the Royal Society of Chemistry journal Chemical Science.The NPL findings are reported in the Royal Society of Chemistry journal Chemical Science.